keyword
https://read.qxmd.com/read/38649099/modeling-an-evaluation-of-the-efficacy-of-the-novel-neuroanalgesic-drug-mirogabalin-for-diabetic-peripheral-neuropathic-pain-and-postherpetic-neuralgia-therapy
#21
JOURNAL ARTICLE
Li-Mian Hong, Jian-Min Liu, Lei Lin, Chun-Chun Huang, Rui Chen, Wei-Wei Lin
Diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN) are challenging and often intractable complex medical conditions, with a substantial impact on the quality of life. Mirogabalin, a novel voltage-gated Ca2+ channel α2δ ligand, was approved for the indication of DPNP and PHN. However, the time course of effects has not yet been clarified.We aimed to establish pharmacodynamic and placebo effect models of mirogabalin and pregabalin in DPNP and PHN, and to quantitatively compare the efficacy characteristics (maximum efficacy, onset time, and other pharmacodynamic parameters) and safety of mirogabalin and pregabalin...
April 20, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38649032/potential-role-of-oxytocin-in-the-regulation-of-memories-and-treatment-of-memory-disorders
#22
JOURNAL ARTICLE
Vaibhav Walia, Pranay Wal, Shweta Mishra, Ankur Agrawal, Sourabh Kosey, Aditya Dilipkumar Patil
Oxytocin (OXT) is an "affiliative" hormone or neurohormone or neuropeptide consists of nine amino acids, synthesized in magnocellular neurons of paraventricular (PVN) and supraoptic nuclei (SON) of hypothalamus. OXT receptors are widely distributed in various region of brain and OXT has been shown to regulate various social and nonsocial behavior. Hippocampus is the main region which regulates the learning and memory. Hippocampus particularly regulates the acquisition of new memories and retention of acquired memories...
April 20, 2024: Peptides
https://read.qxmd.com/read/38648979/antibody-drug-conjugates-in-lung-and-breast-cancer-current-evidence-and-future-directions-a-position-statement-from-the-etop-ibcsg-partners-foundation
#23
REVIEW
S Peters, S Loi, F André, S Chandarlapaty, E Felip, S P Finn, P A Jänne, K M Kerr, E Munzone, A Passaro, M Pérol, E F Smit, C Swanton, G Viale, R A Stahel
Following the approval of the first antibody-drug conjugates (ADCs) in the early 2000s, development has increased dramatically, with 14 ADCs now approved and >100 in clinical development. In lung cancer, trastuzumab deruxtecan (T-DXd) is approved in human epidermal growth factor receptor 2 (HER2)-mutated, unresectable or metastatic non-small cell lung cancer, with ADCs targeting HER3 (patritumab deruxtecan), trophoblast cell-surface antigen 2 (datopotamab deruxtecan and sacituzumab govitecan [SG]) and mesenchymal-epithelial transition factor (telisotuzumab vedotin) in late-stage clinical development...
April 20, 2024: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/38648977/understanding-health-equity-in-patient-reported-outcomes
#24
JOURNAL ARTICLE
Lourdes G Ramirez, Margee Louisias, Princess U Ogbogu, Alanna Stinson, Ruchi Gupta, Samantha Sansweet, Tarandeep Singh, Andrea Apter, Bridgette L Jones, Sharmilee M Nyenhuis
Patient reported outcomes (PROs) are measures of patients' health that are conveyed directly by individual patients. These measures serve as instruments to evaluate the impact of interventions on any aspect of patients' health, from specific symptoms to broader quality-of-life indicators. However, their effectiveness relies on capturing relevant factors accurately. While commonly utilized in clinical trials, PROs extend their influence across healthcare settings, informing clinicians, healthcare payers, regulators, and administrators to guide quality improvement and reimbursement decisions...
April 20, 2024: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38648916/efficacy-and-safety-of-colchicine-for-atrial-fibrillation-prevention-an-updated-meta-analysis-of-randomized-controlled-trials
#25
JOURNAL ARTICLE
Xu Tian, Nan Zhang, Panagiotis Korantzopoulos, George Bazoukis, Konstantinos P Letsas, Gary Tse, Tong Liu
BACKGROUND: Atrial fibrillation (AF), the most common arrhythmia, is closely related to inflammation. Colchicine has the potent anti-inflammatory effects. Several randomized clinical trials (RCTs) have evaluated the efficacy and safety of colchicine in the prevention of AF but the results are inconsistent. OBJECTIVE: The purpose of our study was to evaluate the impact of colchicine on AF. METHOD AND RESULTS: PubMed, EMBASE, Web of Science, Cochrane Library and ClinicalTrials...
April 20, 2024: International Journal of Cardiology
https://read.qxmd.com/read/38648896/efficacy-and-safety-of-withholding-antimicrobial-therapy-in-children-with-cancer-fever-and-neutropenia-with-a-demonstrated-viral-respiratory-infection-a-randomized-clinical-trial
#26
JOURNAL ARTICLE
J P Torres, C Ibañez, R Valenzuela, S Bahamondes, V De la Maza, M Villarroel, P Coria, V Contardo, A M Álvarez, M Zubieta, V Gutierrez, K Ducasse, D Martínez, M E Santolaya
OBJECTIVES: To validate the efficacy and safety of withholding antimicrobial therapy in a new cohort of children with cancer and febrile neutropenia (FN) having a demonstrated viral respiratory tract infection (RTI). METHODS: Prospective, multicenter, non-inferiority, randomized study, approved by the ethical committee, in children presenting with FN at seven hospitals in Chile, evaluated at admission for diagnosis of bacterial and viral pathogens. Children who were positive for a respiratory virus (RV), negative for a bacterial pathogen and had a favorable evolution after 48-72 hours of antimicrobial therapy were randomized to either maintain or withhold antimicrobial therapy...
April 20, 2024: Clinical Microbiology and Infection
https://read.qxmd.com/read/38648861/removal-of-horizontally-impacted-mandibular-third-molars-using-the-three-piece-or-t-shaped-tooth-sectioning-method
#27
JOURNAL ARTICLE
Xianyi He, Yichen Gao, Jie Shen, Qing Pan, Junliang Chen, Yun He
BACKGROUND: The extraction of horizontally impacted mandibular third molars (HM3) can be a complicated surgery. Appropriate tooth sectioning methods can reduce the operation time and postoperative complications. PURPOSE: The current study compares operative time and postoperative pain between HM3 removed using the three-piece or T-shaped tooth sectioning techniques. STUDY DESIGN, SETTING, SAMPLE: A randomized single-blind prospective clinical trial on HM3 extraction was carried out between June and December 2022 in the Department of Oral and Maxillofacial Surgery, the Affiliated Stomatological Hospital, Southwest Medical University...
April 5, 2024: Journal of Oral and Maxillofacial Surgery
https://read.qxmd.com/read/38648848/life-years-gained-from-the-fda-accelerated-approval-program-in-oncology-a-portfolio-model
#28
JOURNAL ARTICLE
Ágnes Benedict, Gábor Szabó, Kinga Marczell, Bridget Doherty, Silas Martin
BACKGROUND: Although the FDA Accelerated Approval Program (AAP) has come under scrutiny, the population-level health benefit of the program has not been quantified. Therefore, the objective of this study was to estimate the number of life years gained among patients with cancer that can be attributable to the therapies receiving FDA accelerated approvals in oncology between 2006 and 2022 in the United States. METHODS: The data sources used were FDA listings, FDA approval letters and labels, published clinical trial data and other publications including relative effectiveness estimates, and the Ipsos Oncology Uptake Tool for product uptake...
April 22, 2024: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/38648685/celiac-disease-hope-for-new-treatments-beyond-a-gluten-free-diet
#29
REVIEW
Maxim D'heedene, Tim Vanuytsel, Lucas Wauters
BACKGROUND & AIMS: Celiac disease (CD) is a chronic inflammatory disease of the small intestine induced and maintained by gluten ingestion in susceptible individuals. Current treatment consists of strict adherence to a lifelong gluten-free diet (GFD) which is considered safe and effective in the large majority of patients. However, since adherence to a GFD is difficult and has a negative impact on quality of life, an increasing interest in other treatment options has emerged. Moreover, in some individuals a GFD is not sufficiently effective, necessitating alternative treatments...
April 15, 2024: Clinical Nutrition
https://read.qxmd.com/read/38648517/support-groups-versus-primary-mental-healthcare-on-disability-and-continuity-of-care-community-trial-support-groups-for-recovery
#30
JOURNAL ARTICLE
Felipe Agudelo-Hernández, Ana Giraldo Alvarez, Rodrigo Rojas-Andrade
Based on the need to implement strategies to reduce recovery gaps in mental health with the community as axes of recovery, the objective of the present study was to assess the impact on psychosocial disability and care continuity in individuals with suicidal behavior, of the clinical and community components of the Mental Health Gap Action Program (mhGAP), versus exclusive psychiatric care. For this, a controlled community trial carried out in 2023 was conducted, comprising intervention groups: Support Group (SG), mhGAP Group (mhGAPG) and a Control Group (CG)...
April 22, 2024: Psychological Reports
https://read.qxmd.com/read/38648106/intermittent-exotropia-the-effect-of-alternating-occlusion-therapy-on-control-of-strabismus
#31
REVIEW
Martin Boersma
BACKGROUND: Intermittent exotropia is a common form of pediatric strabismus characterized by intermittent misalignment of the eyes. This study investigated the clinical effectiveness of alternating occlusion therapy as a non-surgical alternative for children aged 3-10 with intermittent exotropia. METHODS: A comprehensive review of recent research, including randomized controlled trials and case series, was conducted. These studies utilized standardized control scores to assess the impact of alternating occlusion therapy on both distance and near control of alignment...
April 22, 2024: Journal of Binocular Vision and Ocular Motility
https://read.qxmd.com/read/38647229/impact-of-american-diabetes-association-2022-guidelines-on-prescribing-rates-of-sodium-glucose-cotransporter-2-inhibitors-in-ambulatory-care-organization-patients-with-type-2-diabetes
#32
JOURNAL ARTICLE
Alexis R Bogannam, Ewan McNicol, Kevin DeLeonardo, Ashwini Ranade, Kathy Zaiken
Background: Recent clinical trials and guideline updates have highlighted the efficacy and safety of sodium-glucose cotransporter-2 inhibitor (SGLT2i) use in patients with type 2 diabetes (T2D) and comorbidities including atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or heart failure (HF). Objective: This study assesses the rates of guideline-based prescribing of SGLT2i in patients with T2D and one or more of the following comorbidities: ASCVD, CKD, or HF, prior to and after the 2022 American Diabetes Association (ADA) guideline publication within the Atrius Health clinical pharmacy, internal medicine, and specialty medicine departments...
April 22, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38647197/alzheimer-s-disease-genetic-risk-score-and-neuroimaging-in-the-finger-lifestyle-trial
#33
JOURNAL ARTICLE
Gazi Saadmaan, Maria Carolina Dalmasso, Alfredo Ramirez, Mikko Hiltunen, Nina Kemppainen, Jenni Lehtisalo, Francesca Mangialasche, Tiia Ngandu, Juha Rinne, Hilkka Soininen, Ruth Stephen, Miia Kivipelto, Alina Solomon
INTRODUCTION: We assessed a genetic risk score for Alzheimer's disease (AD-GRS) and apolipoprotein E (APOE4) in an exploratory neuroimaging substudy of the FINGER trial. METHODS: 1260 at-risk older individuals without dementia were randomized to multidomain lifestyle intervention or health advice. N = 126 participants underwent magnetic resonance imaging (MRI), and N = 47 positron emission tomography (PET) scans (Pittsburgh Compund B [PiB], Fluorodeoxyglucose) at baseline; N = 107 and N = 38 had repeated 2-year scans...
April 22, 2024: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
https://read.qxmd.com/read/38646654/the-hsp90-inhibitor-hvh-2930-exhibits-potent-efficacy-against-trastuzumab-resistant-her2-positive-breast-cancer
#34
JOURNAL ARTICLE
Minsu Park, Eunsun Jung, Jung Min Park, Soeun Park, Dongmi Ko, Juyeon Seo, Seongjae Kim, Kee Dal Nam, Yong Koo Kang, Lee Farrand, Van-Hai Hoang, Cong-Truong Nguyen, Minh Thanh La, Gibeom Nam, Hyun-Ju Park, Jihyae Ann, Jeewoo Lee, Yoon-Jae Kim, Ji Young Kim, Jae Hong Seo
Rationale: Resistance to targeted therapies like trastuzumab remains a critical challenge for HER2-positive breast cancer patients. Despite the progress of several N-terminal HSP90 inhibitors in clinical trials, none have achieved approval for clinical use, primarily due to issues such as induction of the heat shock response (HSR), off-target effects, and unfavorable toxicity profiles. We sought to examine the effects of HVH-2930, a novel C-terminal HSP90 inhibitor, in overcoming trastuzumab resistance. Methods: The effect of HVH-2930 on trastuzumab-sensitive and -resistant cell lines in vitro was evaluated in terms of cell viability, expression of HSP90 client proteins, and impact on cancer stem cells...
2024: Theranostics
https://read.qxmd.com/read/38646153/inhaled-no-at-a-crossroads-in-cardiac-surgery-current-need-to-improve-mechanistic-understanding-clinical-trial-design-and-scientific-evidence
#35
REVIEW
Stefan Muenster, Iratxe Zarragoikoetxea, Andrea Moscatelli, Joan Balcells, Philippe Gaudard, Philippe Pouard, Nandor Marczin, Stefan P Janssens
Inhaled nitric oxide (NO) has been used in pediatric and adult perioperative cardiac intensive care for over three decades. NO is a cellular signaling molecule that induces smooth muscle relaxation in the mammalian vasculature. Inhaled NO has the unique ability to exert its vasodilatory effects in the pulmonary vasculature without any hypotensive side-effects in the systemic circulation. In patients undergoing cardiac surgery, NO has been reported in numerous studies to exert beneficial effects on acutely lowering pulmonary artery pressure and reversing right ventricular dysfunction and/or failure...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38645900/supporting-the-implementation-of-written-exposure-therapy-for-posttraumatic-stress-disorder-in-an-obstetrics-substance-use-disorder-clinic-in-the-northeastern-united-states
#36
JOURNAL ARTICLE
Sarah E Valentine, Laura B Godfrey, Resham Gellatly, Emilie Paul, Caitlin Clark, Karissa Giovannini, Kelley A Saia, Yael I Nillni
Pregnant people with comorbid posttraumatic stress disorder (PTSD) and substance use disorder (SUD) constitute a highly vulnerable population. PTSD and SUD confer risks to both the pregnant person and the fetus, including a host of physical and mental health consequences. When PTSD and SUD co-occur, potential negative impacts are amplified, and the symptoms of each may exacerbate and maintain the other. Pregnancy often increases engagement in the healthcare system, presenting a unique and critical opportunity to provide PTSD and SUD treatment to birthing people motivated to mitigate risks of losing custody of their children...
December 15, 2023: SSM Ment Health
https://read.qxmd.com/read/38645300/clinical-utility-of-metagenomic-next-generation-sequencing-in-fever-of-undetermined-origin
#37
JOURNAL ARTICLE
Marilyne Daher, Roumen Iordanov, Mayar Al Mohajer, M Rizwan Sohail, Kristen Andrews Staggers, Ahmed Mufeed Hamdi
BACKGROUND: Metagenomic next-generation sequencing (mNGS) is a novel diagnostic tool increasingly used in the field of infectious diseases. Little guidance is available regarding its appropriate use in different patient populations and clinical syndromes. We aimed to review the clinical utility of mNGS in patients with a specific clinical syndrome and identify factors that may increase its utility. METHODS: We retrospectively reviewed charts of 72 non-immunocompromised adults hospitalized with the clinical syndrome of 'fever of undetermined origin' and underwent mNGS testing...
2024: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38645191/factors-associated-with-tuberculosis-treatment-initiation-among-bacteriologically-negative-individuals-evaluated-for-tuberculosis-an-individual-patient-data-meta-analysis
#38
Sun Kim, Melike Hazal Can, Tefera B Agizew, Andrew F Auld, Maria Elvira Balcells, Stephanie Bjerrum, Keertan Dheda, Susan E Dorman, Aliasgar Esmail, Katherine Fielding, Alberto L Garcia-Basteiro, Colleen F Hanrahan, Wakjira Kebede, Mikashmi Kohli, Anne F Luetkemeyer, Carol Mita, Byron W P Reeve, Denise Rossato Silva, Sedona Sweeney, Grant Theron, Anete Trajman, Anna Vassall, Joshua L Warren, Marcel Yotebieng, Ted Cohen, Nicolas A Menzies
BACKGROUND: Globally, over one-third of pulmonary tuberculosis (TB) disease diagnoses are made based on clinical criteria after a negative diagnostic test result. Understanding factors associated with clinicians' decisions to initiate treatment for individuals with negative test results is critical for predicting the potential impact of new diagnostics. METHODS: We performed a systematic review and individual patient data meta-analysis using studies conducted between January/2010 and December/2022 (PROSPERO: CRD42022287613)...
April 8, 2024: medRxiv
https://read.qxmd.com/read/38645003/pilot-trial-of-perampanel-on-peritumoral-hyperexcitability-and-clinical-outcomes-in-newly-diagnosed-high-grade-glioma
#39
Steven Tobochnik, Michael S Regan, Maria K C Dorotan, Dustine Reich, Emily Lapinskas, Md Amin Hossain, Sylwia A Stopka, Sandro Santagata, Melissa M Murphy, Omar Arnaout, Wenya L Bi, E Antonio Chiocca, Alexandra J Golby, Michael A Mooney, Timothy R Smith, Keith L Ligon, Patrick Y Wen, Nathalie Y R Agar, Jong Woo Lee
Background Glutamatergic neuron-glioma synaptogenesis and peritumoral hyperexcitability promote glioma growth in a positive feedback loop. The objective of this study was to evaluate the feasibility and estimated effect sizes of the AMPA-R antagonist, perampanel, on intraoperative electrophysiologic hyperexcitability and clinical outcomes. Methods An open-label trial was performed comparing perampanel to standard of care (SOC) in patients undergoing resection of newly-diagnosed radiologic high-grade glioma...
April 18, 2024: medRxiv
https://read.qxmd.com/read/38644951/the-interplay-between-diabetes-and-oral-health-a-comprehensive-bibliometric-analysis-of-clinical-trials-1967-2024
#40
REVIEW
Namrata Dagli, Mainul Haque, Santosh Kumar
Recognizing the complex interaction between diabetes and oral health is crucial, considering the increasing worldwide prevalence of these conditions. This bibliometric analysis delves into the extensive body of literature concerning the impact of diabetes on oral health, utilizing data retrieved from PubMed. The publishing trends indicate a growing research interest in the field over time, with notable peaks and declines. Coauthorship analyses of authors and institutions illuminated collaborative networks within the research community...
April 2024: Curēus
keyword
keyword
98842
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.